PRISE EN CHARGE DES CAS

Filtres

Résultats

Rapport d'Activités PNLT.Cameroun.2021

Date de publication : 2021
Auteurs: Programme national de lutte contre la tuberculoseprise_en_charge_des_casmaladies_transmissiblesrapport_dactivitesfr

Rapport d'activités PNLT.Cameroun.2019

Date de publication : 2019
Auteurs: Programme National deLlutte contre la Tuberculoseprise_en_charge_des_casmaladies_transmissiblesrapport_dactivitesfr

Rapport Annuel PNLT.Cameroun.2023

Date de publication : 2023
Auteurs: prise_en_charge_des_casmaladies_transmissiblesrapport_dactivitesfr
Thumbnail

Seroprevalence of SARS-CoV-2 (COVID-19) among Health Care Workers in Three Health Facilities of Yaoundé, Center Region of Cameroon.2021

Date de publication : 2021-12-13
Auteurs: Philippe Salomon Nguwoh, Akenji Blaise Mboringong, Joseph Fokam, et al.prise_en_charge_des_casmaladies_transmissiblesarticles_scientifiquesfr

Introduction: Coronavirus Disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) first appeared in December 2019 in Wuhan, China and has subsequently become a worldwide pandemic. During the pandemic, health care workers (HCWs) were very exposed to COVID-19 infected patients. The aim of this study was to determine seroprevalence of SARS-CoV-2 (COVID-19) among HCWs in three health facilities of Yaounde. Methods: A cross-sectional study involving 368 HCWs was conducted from January 18th to February 13th, 2021, in three health facilities located in city of Yaounde. Data of study participants were collected by face-to-face interviews using standard questionnaire.…

Guide technique TB multirésistante.Cameroun.2025

Date de publication : 2025
Auteurs: prise_en_charge_des_casmaladies_transmissiblesguidesfr
Thumbnail

Diagnostic performance evaluation of the Abbott Bioline™ HIV-Syphilis Duo rapid test at the national public health laboratory, Yaounde-Cameroon.2026

Date de publication : 2026-01-05
Auteurs: Philippe Salomon Nguwoh, Christian Taheu Ngounouh, René Ghislain Essomba, et al.prise_en_charge_des_casmaladies_transmissiblesarticles_scientifiquesfr

Background The Bioline™ HIV/Syphilis Duo rapid diagnostic test (RDT) is the first World Health Organization (WHO) prequalified Duo RDT for the simultaneous detection of human immunodeficiency virus (HIV) and Treponema pallidum antibodies in human blood samples. Several studies have shown the satisfactory diagnostic performance of this test among vulnerable populations such as pregnant women. However, the diagnostic performance of this Duo test is scarce in the general population in Cameroon. The present study aimed to assess the diagnostic performance of the Abbot Bioline™ HIV/Syphilis Duo RDT in Cameroon. Methods A laboratory based cross-sectional and comparative study was conducted from January,…

Guide technique TB sensible.Cameroun.2019

Date de publication : 2019
Auteurs: MINSANTEprise_en_charge_des_casmaladies_transmissiblesguidesfr

Final report on Stigmatization of TB Patients and Health Care Providers.Cameroon.2021

Date de publication : 2022
Auteurs: Programme National deLlutte contre la Tuberculoseprise_en_charge_des_casmaladies_transmissiblesarticles_scientifiquesen
Thumbnail

Diagnostic performance of the Hightop Rapid Diagnostic Test for the detection of anti-Treponema pallidum antibodies in Cameroon: a laboratory-based crosssectional and comparative study.2025.Pdf

Date de publication : 2025-08-11
Auteurs: Christian Taheu Ngounouh, Philippe Salomon Nguwoh, Joseph Fokam, et al.prise_en_charge_des_casmaladies_transmissiblesarticles_scientifiques

Objective The study was conducted to assess the diagnostic performance of the Hightop Syphilis Rapid Diagnostic Test (RDT) in comparison with the ELISA test used as a reference method. Design A laboratory-based cross-sectional and comparative study was conducted to assess the diagnostic performance of the Hightop Syphilis RDT. Setting Blood samples obtained from adult participants in eight health facilities were analysed at the National Public Health Laboratory (NPHL), Ministry of Public Health, Yaounde, Cameroon. Participants From 29 April to 25 August 2023, 583 adult participants of both sexes (aged ≥21 years), including both syphilis positive and syphilis negative, were recruited…

Rapport enquêtes traitement de masse onchocercose.District Olamze.Cameroon.2023

Date de publication : 2023
Auteurs: MINSANTEprise_en_charge_des_casmaladies_tropicales_negligeesrapport_dactivitesfr

Du 23 au 24 Septembre 2023 s’est tenue la formation des 24 participants présélectionnés pour l’enquête de réalisation des évaluations de la transmission de l’onchocercose des enfants scolarisés et non scolarisés âgées de (5 à 9 ans),organisé par le Ministère de la Santé Publique. Apres ces jours de formation nous avions été capacités et en sommes sortis des experts, et l’équipe N°20 du District de Santé d’Olamze nous a été confiée et les activités ont pris réellement corps le 25 Septembre 2023 pour 8 jours de travail de terrain.

Scroll to Top